Literature DB >> 20222926

Ustekinumab induces rapid clearing of erythrodermic psoriasis after failure of antitumour necrosis factor therapies.

J Santos-Juanes, P Coto-Segura, A Mas-Vidal, C Galache Osuna.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20222926     DOI: 10.1111/j.1365-2133.2010.09669.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

Review 1.  Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances.

Authors:  Shuai Shao; Gang Wang; Emanual Maverakis; Johann E Gudjonsson
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

2.  Ustekinumab: differential use in psoriasis.

Authors:  Elizabeth E Uhlenhake; David A Mehregan
Journal:  Clin Cosmet Investig Dermatol       Date:  2011-07-01

3.  Erythrodermic Psoriasis Treated with Golimumab: A Case Report.

Authors:  Won-Ku Lee; Gun-Wook Kim; Hyun-Ho Cho; Won-Jeong Kim; Je-Ho Mun; Margaret Song; Hoon-Soo Kim; Hyun-Chang Ko; Moon-Bum Kim; Byung-Soo Kim
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

4.  Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: a report of two cases.

Authors:  Rosita Saraceno; Marina Talamonti; Marco Galluzzo; Andrea Chiricozzi; Antonio Costanzo; Sergio Chimenti
Journal:  Case Rep Dermatol       Date:  2013-09-26

5.  Erythrodermic Psoriasis Improved by Ustekinumab: A Report of Two Cases.

Authors:  Ye Seul Kim; Hyun Ju Kim; Sanghoon Lee; Young Lip Park
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444

6.  Erythrodermic psoriasis: pathophysiology and current treatment perspectives.

Authors:  Rasnik K Singh; Kristina M Lee; Derya Ucmak; Merrick Brodsky; Zaza Atanelov; Benjamin Farahnik; Michael Abrouk; Mio Nakamura; Tian Hao Zhu; Wilson Liao
Journal:  Psoriasis (Auckl)       Date:  2016-07-20

Review 7.  An evolution in switching therapy for psoriasis patients who fail to meet treatment goals.

Authors:  Francisco Kerdel; Martin Zaiac
Journal:  Dermatol Ther       Date:  2015-08-10       Impact factor: 2.851

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.